NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care.

June 2019: The FebriDx test is now an all-in-one test that includes a built-in lancet, blood collection and buffer delivery system, which removes the need to transfer the blood sample to a test device. The test results are now available within 10 minutes. A new MIB is planned in 2019/20.

What are MIBs?